<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Methylphenidate</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00422</strong>&#160; (APRD00657)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved, investigational</td></tr><tr><th>Description</th><td><p>A central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00422/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00422/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00422.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00422.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00422.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00422.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00422.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00422">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>Methylphenidatum</td><td>Latin</td><td>INN</td></tr><tr><td>Metilfenidato</td><td>Italian</td><td>INN</td></tr><tr><td>MPH</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Salts</th><td class="table-container"><table class="inner">
  <thead>
    <tr>
      <th>Name/CAS</th>
      <th>Structure</th>
      <th>Properties</th>
      <th></th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>
          <strong>Methylphenidate Hydrochloride </strong>
          <div class="cas"></div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT000117/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT000117/thumb.png"></a></td>
        <td>
            <ul>
              <li>InChI Key: JUMYIBMBTDDLNG-UHFFFAOYNA-N</li>
              <li>Monoisotopic Mass: 269.118256596</li>
              <li>Average Mass: 269.767</li>
            </ul>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT000117">DBSALT000117</a></td>
      </tr>
  </tbody>
</table></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Concerta</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Daytrana</td><td>Noven Therapeutics, LLC</td></tr><tr><td>Equasym XL</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Medikinet XL</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Metadate</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Methylin</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Quillivant</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Quillivant XR</td><td>NextWave Pharmaceuticals </td></tr><tr><td>Riphenidate</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Ritalin</td><td>Novartis</td></tr><tr><td>Rubifen SR</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/central-nervous-system-stimulants">Central Nervous System Stimulants</a></li>
<li><a href="/mesh/dopamine-uptake-inhibitors">Dopamine Uptake Inhibitors</a></li></ul></td></tr><tr><th>CAS number</th><td>113-45-1</td></tr><tr><th>Weight</th><td>Average: 233.3062<br>Monoisotopic: 233.141578857</td></tr><tr><th>Chemical Formula</th><td>C<sub>14</sub>H<sub>19</sub>NO<sub>2</sub></td></tr><tr><th>InChI Key</th><td>DUGOZIWVEXMGBE-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">methyl 2-phenyl-2-(piperidin-2-yl)acetate</div></td></tr><tr><th>SMILES</th><td><div class="wrap">COC(=O)C(C1CCCCN1)C1=CC=CC=C1</div></td></tr><tr><th>Mass Spec</th><td><a href="/system/mass_specs/DB00422.gif?1265922772">show</a>(7.79 KB)</td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Benzenoids</td></tr><tr><th>Class</th><td>Benzene and Substituted Derivatives</td></tr><tr><th>Subclass</th><td>Phenylacetic Acid Derivatives</td></tr><tr><th>Direct parent</th><td>Phenylacetic Acid Derivatives</td></tr><tr><th>Alternative parents</th><td>Piperidines; Carboxylic Acid Esters; Ethers; Enolates; Dialkylamines; Polyamines</td></tr><tr><th>Substituents</th><td>piperidine; carboxylic acid ester; secondary amine; secondary aliphatic amine; enolate; polyamine; carboxylic acid derivative; ether; amine; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the phenylacetic acid derivatives. These are compounds containing a phenylacetic acid moiety, which consists of a phenyl group substituted at the second position by an acetic acid.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.</td></tr><tr><th>Pharmacodynamics</th><td>Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Methylphenidate also blocks the reuptake of norepinephrine and dopamine. Its mechanisms appear to be similar to those of dextroamphetamine.  Furthermore, it is a racemic mixture comprised of the d- and l-threo enantiomers. The d-threo enantiomer is more pharmacologically active than the l-threo enantiomer. </td></tr><tr><th>Mechanism of action</th><td>Methylphenidate blocks dopamine uptake in central adrenergic neurons by blocking dopamine transport or carrier proteins. Methylphenidate acts at the brain stem arousal system and the cerebral cortex and causes increased sympathomimetic activity in the central nervous system. Alteration of serotonergic pathways via changes in dopamine transport may result.</td></tr><tr><th>Absorption</th><td>Readily absorbed in a biphasic manner when orally administered (tablets) to children diagnosed with ADHD and to healthy adults. In children and adults males, after administration of a single oral dose of Ritalin LA and Ritalin given in two doses 4 hours apart,  peak plasma concentration is reached approximately 2 hours for the first phase and 5-6 hours for the second phase. The absolute oral bioavailability of methylphenidate in children was 22&#177;8% for d-methylphenidate and 5&#177;3% for l-methylphenidate. These low values suggest that methylphenidate is highly metabolized presystemically. </td></tr><tr><th>Volume of distribution</th><td><p>d-methylphenidate = 2.65 L/kg;<br>
l-methylphenidate = 1.80 L/kg;</p></td></tr><tr><th>Protein binding</th><td>Binding to plasma proteins is low (10%-33%). </td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Methylphenidate is hepatically metabolized. More specifically, it is rapidly and extensively metabolized by carboxylesterase CES1A1. Via this enzyme, methylphenidate undergoes de-esterification to ritalinic acid (a-phenyl-2-piperidine acetic acid, PPAA), which has little to no pharmacologic activity.</p></td></tr><tr><th>Route of elimination</th><td>After oral administration of an immediate release formulation of methylphenidate, 78%-97% of the dose is excreted in the urine and 1%-3% in the feces in the form of metabolites within 48-96 hours. Only small quantities (</td></tr><tr><th>Half life</th><td>d-methylphenidate = 3-4 hours;
l-methylphenidate = 1-3 hours; 
Ritalinic acid = 3-4 hours; </td></tr><tr><th>Clearance</th><td><p>Systemic clearance for Ritalin LA and Ritalin tablets is as follows:<br>
d-methylphenidate=  0.40&#177;0.12 L/h/kg;<br>
l-methylphenidate = 0.73&#177;0.28 L/h/kg;</p></td></tr><tr><th>Toxicity</th><td>Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD<sub>50</sub>=190mg/kg (orally in mice)</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.9941</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.9663</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.6564</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.5466</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.7964</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9601</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Inhibitor
        </td>
        <td>0.532</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7897</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.9116</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.5985</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.592</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.897</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.5245</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9265</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8539</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.9328</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.9133
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.9648
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.5759
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.7718 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.8466
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.7491
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Shire development inc</li>
<li>Ucb inc</li>
<li>Novartis pharmaceuticals corp</li>
<li>Mallinckrodt inc</li>
<li>Tris pharma inc</li>
<li>Ortho mcneil janssen pharmaceutical inc</li>
<li>Able laboratories inc</li>
<li>Actavis elizabeth llc</li>
<li>Watson laboratories inc</li>
<li>Ortho-McNeil-Janssen Pharmaceuticals, Inc.</li></ul></td></tr><tr><th>Packagers</th><td><ul><li>Alliant Pharmaceuticals Inc.</li>
<li>Alza Corp.</li>
<li><a href="http://www.apothecon.nl">Apothecon</a></li>
<li><a href="http://bryantranchprepack.com">Bryant Ranch Prepack</a></li>
<li><a href="http://www.cardinal.com">Cardinal Health</a></li>
<li><a href="http://www.caremark.com">Caremark LLC</a></li>
<li><a href="http://www.chattem.com">Chattem Chemicals Inc.</a></li>
<li>D.M. Graham Laboratories Inc.</li>
<li><a href="http://www.drxdispensing.com">Dispensing Solutions</a></li>
<li><a href="http://www.elan.com">Elan Pharmaceuticals Inc.</a></li>
<li><a href="http://www.eurand.com">Eurand Pharmaceuticals Inc.</a></li>
<li><a href="http://www.janssen-ortho.com">Janssen-Ortho Inc.</a></li>
<li><a href="http://www.majorpharmaceuticals.com">Major Pharmaceuticals</a></li>
<li><a href="http://www.mallinckrodt.com">Mallinckrodt Inc.</a></li>
<li><a href="http://www.mckesson.com">Mckesson Corp.</a></li>
<li>McNeil Laboratories</li>
<li><a href="http://www.novartis.com">Novartis AG</a></li>
<li><a href="http://www.noven.com">Noven Pharmaceuticals Inc.</a></li>
<li><a href="http://www.nucarerx.com">Nucare Pharmaceuticals Inc.</a></li>
<li><a href="http://www.ortho-mcneil.com">Ortho Mcneil Janssen Pharmaceutical Inc.</a></li>
<li><a href="http://www.patriotpharmaceuticals.com">Patriot Pharmaceuticals</a></li>
<li><a href="http://www.pdrx.com">PD-Rx Pharmaceuticals Inc.</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.purduepharma.com">Purdue Pharma LP</a></li>
<li><a href="http://www.worldoftest.com">Qualitest</a></li>
<li>Quality Care</li>
<li><a href="http://www.sandoz.ca">Sandoz</a></li>
<li>Sciele Pharma Inc.</li>
<li><a href="http://www.shire.com">Shire Inc.</a></li>
<li><a href="http://statrxusa.exporterus.com">Stat Rx Usa</a></li>
<li>Superior Pharmeceuticals</li>
<li><a href="http://www.ucb.com">UCB Pharma</a></li>
<li>Upstate Pharma LLC</li>
<li><a href="http://www.watson.com">Watson Pharmaceuticals</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Capsule, extended release</td><td>Oral</td><td></td></tr><tr><td>Patch</td><td>Transdermal</td><td>10 mg/9 hr; 15 mg/9 hr; 20 mg/9 hr; 30 mg/9 hr</td></tr><tr><td>Solution</td><td>Oral</td><td>5 mg/mL; 10mg/5mL</td></tr><tr><td>Suspension, extended release</td><td>Oral</td><td>25 mg/5 mL</td></tr><tr><td>Tablet</td><td>Oral</td><td>5 mg, 10 mg, 20 mg</td></tr><tr><td>Tablet, chewable</td><td>Oral</td><td>2.5 mg, 5 mg, 10 mg</td></tr><tr><td>Tablet, extended release</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr><th>Prices</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="prices"><thead><tr><th>Unit description</th><th>Cost</th><th>Unit</th></tr></thead><tbody><tr><td>Daytrana 30 15 mg/9hr Patches Box</td><td>175.64USD</td><td>box</td></tr><tr><td>Daytrana 30 30 mg/9hr Patches Box</td><td>174.73USD</td><td>box</td></tr><tr><td>Daytrana 30 10 mg/9hr Patches Box</td><td>172.78USD</td><td>box</td></tr><tr><td>Daytrana 30 20 mg/9hr Patches Box</td><td>168.72USD</td><td>box</td></tr><tr><td>Methylphenidate hcl powder</td><td>44.62USD</td><td>g</td></tr><tr><td>Concerta er 54 mg tablet</td><td>25.45USD</td><td>tablet</td></tr><tr><td>Concerta er 36 mg tablet</td><td>23.38USD</td><td>tablet</td></tr><tr><td>Concerta er 27 mg tablet</td><td>22.65USD</td><td>tablet</td></tr><tr><td>Concerta er 18 mg tablet</td><td>22.11USD</td><td>tablet</td></tr><tr><td>Metadate cd 50 mg capsule</td><td>7.08USD</td><td>capsule</td></tr><tr><td>Metadate cd 60 mg capsule</td><td>7.02USD</td><td>capsule</td></tr><tr><td>Concerta 54 mg Controlled Release Tabs</td><td>6.18USD</td><td>tab</td></tr><tr><td>Metadate cd 40 mg capsule</td><td>5.77USD</td><td>capsule</td></tr><tr><td>Concerta 36 mg Controlled Release Tabs</td><td>5.72USD</td><td>tab</td></tr><tr><td>Focalin xr 30 mg capsule</td><td>5.42USD</td><td>capsule</td></tr><tr><td>Focalin XR 20 mg 24 Hour Capsule</td><td>5.31USD</td><td>capsule</td></tr><tr><td>Daytrana 10 mg/9 hr patch</td><td>5.16USD</td><td>patch</td></tr><tr><td>Daytrana 15 mg/9 hr patch</td><td>5.16USD</td><td>patch</td></tr><tr><td>Daytrana 20 mg/9 hour patch</td><td>5.16USD</td><td>patch</td></tr><tr><td>Daytrana 30 mg/9 hour patch</td><td>5.16USD</td><td>patch</td></tr><tr><td>Focalin xr 15 mg capsule</td><td>5.16USD</td><td>capsule</td></tr><tr><td>Focalin xr 20 mg capsule</td><td>5.16USD</td><td>capsule</td></tr><tr><td>Focalin XR 30 mg 24 Hour Capsule</td><td>5.15USD</td><td>capsule</td></tr><tr><td>Focalin xr 10 mg capsule</td><td>5.02USD</td><td>capsule</td></tr><tr><td>Concerta 18 mg Controlled Release Tabs</td><td>5.0USD</td><td>tab</td></tr><tr><td>Concerta 27 mg Controlled Release Tabs</td><td>5.0USD</td><td>tab</td></tr><tr><td>Focalin XR 10 mg 24 Hour Capsule</td><td>4.96USD</td><td>capsule</td></tr><tr><td>Focalin xr 5 mg capsule</td><td>4.95USD</td><td>capsule</td></tr><tr><td>Concerta 54 mg tablet sa</td><td>4.91USD</td><td>tablet</td></tr><tr><td>Focalin XR 15 mg 24 Hour Capsule</td><td>4.89USD</td><td>capsule</td></tr><tr><td>Focalin XR 5 mg 24 Hour Capsule</td><td>4.83USD</td><td>capsule</td></tr><tr><td>Ritalin la 40 mg capsule</td><td>4.55USD</td><td>capsule</td></tr><tr><td>Concerta 36 mg tablet sa</td><td>4.51USD</td><td>tablet</td></tr><tr><td>Ritalin la 30 mg capsule</td><td>4.43USD</td><td>capsule</td></tr><tr><td>Ritalin LA 10 mg 24 Hour Capsule</td><td>4.42USD</td><td>capsule</td></tr><tr><td>Ritalin LA 20 mg 24 Hour Capsule</td><td>4.42USD</td><td>capsule</td></tr><tr><td>Ritalin LA 30 mg 24 Hour Capsule</td><td>4.42USD</td><td>capsule</td></tr><tr><td>Ritalin LA 40 mg 24 Hour Capsule</td><td>4.42USD</td><td>capsule</td></tr><tr><td>Concerta 27 mg tablet sa</td><td>4.37USD</td><td>tablet</td></tr><tr><td>Ritalin la 10 mg capsule</td><td>4.33USD</td><td>capsule</td></tr><tr><td>Ritalin la 20 mg capsule</td><td>4.33USD</td><td>capsule</td></tr><tr><td>Concerta 18 mg tablet sa</td><td>4.27USD</td><td>tablet</td></tr><tr><td>Metadate cd 20 mg capsule</td><td>4.24USD</td><td>capsule</td></tr><tr><td>Metadate cd 30 mg capsule</td><td>4.24USD</td><td>capsule</td></tr><tr><td>Metadate cd 10 mg capsule</td><td>4.2USD</td><td>capsule</td></tr><tr><td>Methylphenidate er 10 mg tablet</td><td>3.24USD</td><td>tablet</td></tr><tr><td>Ritalin SR 20 mg Controlled Release Tabs</td><td>3.0USD</td><td>tab</td></tr><tr><td>Ritalin sr 20 mg tablet</td><td>2.67USD</td><td>tablet</td></tr><tr><td>Ritalin 20 mg tablet</td><td>1.87USD</td><td>tablet</td></tr><tr><td>Focalin 10 mg tablet</td><td>1.7USD</td><td>tablet</td></tr><tr><td>Ritalin 5 mg tablet</td><td>1.42USD</td><td>tablet</td></tr><tr><td>Metadate er 20 mg tablet</td><td>1.32USD</td><td>tablet</td></tr><tr><td>Methylin ER 20 mg Controlled Release Tabs</td><td>1.3USD</td><td>tab</td></tr><tr><td>Ritalin 10 mg tablet</td><td>1.29USD</td><td>tablet</td></tr><tr><td>Metadate er 10 mg tablet sa</td><td>1.28USD</td><td>tablet</td></tr><tr><td>Focalin 5 mg tablet</td><td>1.26USD</td><td>tablet</td></tr><tr><td>Methylphenidate HCl CR 20 mg Controlled Release Tabs</td><td>1.2USD</td><td>tab</td></tr><tr><td>Methylin er 20 mg tablet</td><td>1.12USD</td><td>tablet</td></tr><tr><td>Methylphenidate HCl 20 mg tablet</td><td>1.05USD</td><td>tablet</td></tr><tr><td>Methylin ER 10 mg</td><td>1.0USD</td><td>tab</td></tr><tr><td>Methylphenidate HCl 10 mg tablet</td><td>0.95USD</td><td>tablet</td></tr><tr><td>Methylphenidate HCl 5 mg tablet</td><td>0.94USD</td><td>tablet</td></tr><tr><td>Methylin er 10 mg tablet</td><td>0.84USD</td><td>tablet</td></tr><tr><td>Focalin 2.5 mg tablet</td><td>0.76USD</td><td>tablet</td></tr><tr><td>Methylin 20 mg tablet</td><td>0.69USD</td><td>tablet</td></tr><tr><td>Methylphenidate 20 mg tablet</td><td>0.69USD</td><td>tablet</td></tr><tr><td>Ritalin 20 mg Tablet</td><td>0.67USD</td><td>tablet</td></tr><tr><td>Ritalin Sr 20 mg Extended-Release Tablet</td><td>0.67USD</td><td>tablet</td></tr><tr><td>Methylin 10 mg tablet</td><td>0.48USD</td><td>tablet</td></tr><tr><td>Methylphenidate 10 mg tablet</td><td>0.48USD</td><td>tablet</td></tr><tr><td>Ritalin 10 mg Tablet</td><td>0.38USD</td><td>tablet</td></tr><tr><td>Apo-Methylphenidate 20 mg Tablet</td><td>0.37USD</td><td>tablet</td></tr><tr><td>Apo-Methylphenidate Sr 20 mg Extended-Release Tablet</td><td>0.37USD</td><td>tablet</td></tr><tr><td>Pms-Methylphenidate 20 mg Tablet</td><td>0.37USD</td><td>tablet</td></tr><tr><td>Sandoz Methylphenidate 20 mg Extended-Release Tablet</td><td>0.37USD</td><td>tablet</td></tr><tr><td>Methylin 5 mg tablet</td><td>0.33USD</td><td>tablet</td></tr><tr><td>Methylphenidate 5 mg tablet</td><td>0.33USD</td><td>tablet</td></tr><tr><td>Apo-Methylphenidate 10 mg Tablet</td><td>0.17USD</td><td>tablet</td></tr><tr><td>Pms-Methylphenidate 10 mg Tablet</td><td>0.17USD</td><td>tablet</td></tr><tr><td>Pms-Methylphenidate 5 mg Tablet</td><td>0.1USD</td><td>tablet</td></tr></tbody></table><div class="alert alert-warning clearfix">DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.</div></td></tr><tr><th>Patents</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="patents"><thead><tr><th>Country</th><th>Patent Number</th><th>Approved</th><th>Expires (estimated)</th></tr></thead><tbody><tr><td>United States</td><td>7691880</td><td>2004-10-07</td><td>2024-10-07</td></tr><tr><td>United States</td><td>5958446</td><td>1992-12-12</td><td>2012-12-12</td></tr><tr><td>Canada</td><td>2355644</td><td>2009-01-20</td><td>2019-12-17</td></tr><tr><td>Canada</td><td>2264852</td><td>2005-11-01</td><td>2017-09-16</td></tr></tbody></table></td></tr><tr id="properties"><th class="divider" colspan="2">Properties</th></tr><tr><th>State</th><td>solid</td></tr><tr><th>Experimental Properties</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr><tr><td>melting point</td><td>224-226 &#176;C</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>water solubility</td><td>1255mg/L</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>logP</td><td>0.20</td><td>HANSCH,C ET AL. (1995), pH 7.2</td></tr><tr><td>pKa</td><td>8.77</td><td>SANGSTER,J (1994)</td></tr></table></td></tr><tr><th>Predicted Properties</th><td class="data-table-container"><table class="table table-condensed table-striped"><thead><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr></thead><tbody><tr><td>water solubility</td><td>1.82e-01 g/l</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>1.47</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>2.25</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#logp_logd">ChemAxon</a></td></tr><tr><td>logS</td><td>-3.1</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>pKa (strongest basic)</td><td>9.09</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>physiological charge</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>hydrogen acceptor count</td><td>2</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>hydrogen donor count</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>polar surface area</td><td>38.33</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topolgical_surface">ChemAxon</a></td></tr><tr><td>rotatable bond count</td><td>4</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>refractivity</td><td>66.73</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#refractivity">ChemAxon</a></td></tr><tr><td>polarizability</td><td>26.21</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>number of rings</td><td>2</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>bioavailability</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>rule of five</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Ghose filter</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Veber's rule</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>MDDR-like rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="references"><th class="divider" colspan="2">References</th></tr><tr><th>Synthesis Reference</th><td><span class="citations"><p><a href="http://www.drugsyn.org/Methylphenidate.htm">DrugSyn.org</a></p></span><a class="wishart-link-out" href="https://www.google.com/?tbm=pts#q=2512572&amp;tbm=pts" target="_blank">US2512572 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><th>General Reference</th><td><span class="citations"><ol>
	<li>Keating GM, McClellan K, Jarvis B: Methylphenidate (<span class="caps">OROS</span> formulation). <span class="caps">CNS</span> Drugs. 2001;15(6):495-500; discussion 501-3. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11524026">Pubmed</a></li>
	<li>Markowitz JS, DeVane CL, Pestreich LK, Patrick KS, Muniz R: A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study. J Child Adolesc Psychopharmacol. 2006 Dec;16(6):687-98. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17201613">Pubmed</a></li>
	<li>Fone KC, Nutt DJ: Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder. Curr Opin Pharmacol. 2005 Feb;5(1):87-93. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15661631">Pubmed</a></li>
	<li>Sharma RP, Javaid JI, Pandey GN, Easton M, Davis JM: Pharmacological effects of methylphenidate on plasma homovanillic acid and growth hormone. Psychiatry Res. 1990 Apr;32(1):9-17. <a href="http://www.ncbi.nlm.nih.gov/pubmed/2190251">Pubmed</a></li>
	<li>Shults T, Kownacki AA, Woods WE, Valentine R, Dougherty J, Tobin T: Pharmacokinetics and behavioral effects of methylphenidate in Thoroughbred horses. Am J Vet Res. 1981 May;42(5):722-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7258793">Pubmed</a><br>
#<span class="caps">FDA</span> label</li>
</ol></span></td></tr><tr><th>External Links</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Resource</th><th>Link</th></tr></thead><tbody><tr><td>KEGG Drug</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?drug:D04999" target="_blank">D04999 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>KEGG Compound</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?cpd:C07196" target="_blank">C07196 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Compound</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=4158" target="_blank">4158 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Substance</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46505929" target="_blank">46505929 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChemSpider</td><td><a class="wishart-link-out" href="http://www.chemspider.com/Chemical-Structure.4015.html" target="_blank">4015 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEBI</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=6887" target="_blank">6887 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEMBL</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL796" target="_blank">CHEMBL796 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Therapeutic Targets Database</td><td><a class="wishart-link-out" href="http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP000024" target="_blank">DAP000024 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PharmGKB</td><td><a class="wishart-link-out" href="http://www.pharmgkb.org/drug/PA450464" target="_blank">PA450464 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drug Product Database</td><td><a class="wishart-link-out" href="http://205.193.93.51/dpdonline/searchRequest.do?din=2249332" target="_blank">2249332 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>RxList</td><td><a class="wishart-link-out" href="http://www.rxlist.com/cgi/generic/methphen.htm" target="_blank">http://www.rxlist.com/cgi/generic/methphen.htm <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drugs.com</td><td><a class="wishart-link-out" href="http://www.drugs.com/methylphenidate.html" target="_blank">http://www.drugs.com/methylphenidate.html <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PDRhealth</td><td><a class="wishart-link-out" href="http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/rit1383.shtml" target="_blank">http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/rit1383.shtml <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Wikipedia</td><td><a class="wishart-link-out" href="http://en.wikipedia.org/wiki/Methylphenidate" target="_blank">Methylphenidate <span class="glyphicon glyphicon-new-window"> </span></a></td></tr></tbody></table></td></tr><tr><th>ATC Codes</th><td>N06BA04<ul class="atc-drug-tree"><li><a href="/atc/N#N">N &#8212; NERVOUS SYSTEM</a></li><li><a href="/atc/N06#N06">N06 &#8212; PSYCHOANALEPTICS</a></li><li><a href="/atc/N06B#N06B">N06B &#8212; PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS</a></li><li><a href="/atc/N06BA#N06BA">N06BA &#8212; Centrally acting sympathomimetics</a></li></ul></td></tr><tr><th>AHFS Codes</th><td><ul><li>28:20.92</li></ul></td></tr><tr><th>PDB Entries</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>FDA label</th><td><a href="/system/fda_labels/DB00422.pdf?1265922799">show</a>(178 KB)</td></tr><tr><th>MSDS</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB00564">Carbamazepine</a></td><td>Carbamazepine may decrease the effect of methylphendiate.</td></tr><tr><td><a href="/drugs/DB00091">Cyclosporine</a></td><td>Methylphenidate increases the effect and toxicity of cyclosporine</td></tr><tr><td><a href="/drugs/DB01170">Guanethidine</a></td><td>Methylphenidate may decrease the effect of guanethidine.</td></tr><tr><td><a href="/drugs/DB01247">Isocarboxazid</a></td><td>Possible hypertensive crisis with this combination</td></tr><tr><td><a href="/drugs/DB00780">Phenelzine</a></td><td>Possible hypertensive crisis with this combination</td></tr><tr><td><a href="/drugs/DB01367">Rasagiline</a></td><td>Possible hypertensive crisis with this combination.</td></tr><tr><td><a href="/drugs/DB00519">Trandolapril</a></td><td>Methylphenidate may antagonize the antihypertensive effect of Trandolapril. Monitor for changes in blood pressure if Methylphenidate is initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB00752">Tranylcypromine</a></td><td>The MAO inhibitor, Tranylcypromine, may increase the vasopressor effect of Methylphenidate. Concomitant therapy is contraindicated.</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><ul><li>Avoid alcohol.</li>
<li>Avoid excessive quantities of coffee or tea (Caffeine).</li>
<li>Take on empty stomach: 1 hour before or 2 hours after meals.</li></ul></td></tr></tbody></table>